Sawaeed Holding P.J.S.C. (ADX:SAWAEED)

CTI BioPharma Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	346	346	346	342	360	335
Market Cap Growth	-	-	1.19%	-4.96%	7.63%	-
Enterprise Value	198	232	308	292	288	291
Last Close Price	6.78	5.02	5.02	4.88	4.92	4.51
PE Ratio	4.56	55.69	54.49	-	38.63	-
PS Ratio	0.90	1.23	2.48	2.79	2.12	1.71
PB Ratio	0.97	0.85	1.11	1.08	1.09	1.05
P/TBV Ratio	1.09	0.93	1.11	1.09	1.11	1.08
P/FCF Ratio	4.49	27.83	39.62	18.89	11.84	71.50
P/OCF Ratio	4.35	26.09	37.20	18.73	11.56	46.61
EV/Sales Ratio	0.51	0.83	2.20	2.38	1.70	1.48
EV/EBITDA Ratio	2.26	40.24	42.56	-	21.71	967.25
EV/EBIT Ratio	2.51	-	148.94	-	32.40	-
EV/FCF Ratio	2.57	18.66	35.18	16.09	9.48	62.09
Debt / Equity Ratio	0.09	0.08	0.10	0.10	0.10	0.04
Debt / EBITDA Ratio	0.36	5.37	4.24	-	2.24	2.32
Debt / FCF Ratio	0.41	2.57	3.60	1.66	1.04	3.00
Asset Turnover	0.92	0.61	0.36	0.31	0.43	0.48
Inventory Turnover	-	-	-	-	601.62	674.50
Quick Ratio	4.48	5.16	7.11	6.23	7.05	6.61
Current Ratio	4.82	5.55	7.45	6.73	7.05	7.12
Return on Equity (ROE)	24.15%	1.72%	2.02%	-4.80%	2.88%	-0.53%
Return on Assets (ROA)	11.74%	-0.15%	0.34%	-2.81%	1.41%	-0.65%
Return on Capital (ROIC)	14.27%	-0.17%	0.37%	-3.16%	1.60%	-0.75%
Return on Capital Employed (ROCE)	19.10%	-	0.60%	-	2.40%	-
Earnings Yield	21.95%	1.80%	1.84%	-4.46%	2.59%	-1.49%
FCF Yield	22.28%	3.59%	2.52%	5.29%	8.45%	1.40%
Dividend Yield	25.99%	35.11%	-	2.05%	6.10%	2.22%
Payout Ratio	118.42%	-	80.36%	-	54.80%	-
Total Shareholder Return	25.99%	35.11%	-	2.05%	6.10%	2.22%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.